Baseline PET Metabolic Tumor Volume Predicts Outcome in Advanced Follicular Lymphoma Patients Who Received First-Line Immunochemotherapy but Not Those Treated with Lenalidomide-Rituximab in the Phase III Relevance Study

A. Cottereau,L. Rebaud,J. Trotman,P. Feugier,L. Nastoupil,E. Bachy,I. Flinn,C. Haioun,L. Ysebaert,N. Bartlett,H. Tilly,R. Casasnovas,R. Ricci,C. Portugues,I. Buvat,M. Meignan,F. Morschhauser

Published 2022 in Blood

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2022
Venue
Blood
Publication date
2022-11-15
Fields of study
Not labeled
Identifiers
DOI 10.1182/blood-2022-159207
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

No citing papers are available for this paper.